
The prosecution strongly rebuked Holmes' claims in their court filings. They challenged the alleged grounds for appeal and cited evidence of misrepresentations about the product made by Holmes. The prosecutors stated that her claims are meritless and highlighted the overwhelming evidence and independent categories of fraudulent statements made by Holmes. They argued that even if there were any missteps in the case, it would not change the outcome given the substantial evidence against her.

During the trial, Holmes' attorneys took issue with the limitations placed on the cross-examination of a key witness. However, the original news article does not provide specific details about the limitations or the witness involved. The attorneys also contested the judge's decision to permit testimony from ex-Theranos clinical lab director Kingshuk Das as a source of information about key events rather than as an expert witness.

The defense team of Elizabeth Holmes based their appeal regarding the testimony of ex-Theranos clinical lab director Kingshuk Das on the grounds that the judge allowed his testimony as a source of information about key events, rather than as an expert witness13. They argued that this decision impacted the fairness of the trial.